Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Hold Rating from Maxim Group

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Hold Rating from Maxim Group


's stock had its "hold" rating reaffirmed by analysts at Maxim Group in a note issued to investors on Thursday. They presently have a $35.00 price objective on the stock.



from Biotech News